Connection

YOCHAI BIRNBAUM to Myocardium

This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Myocardium.
Connection Strength

4.617
  1. Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes. Cardiovasc Drugs Ther. 2025 Feb; 39(1):43-61.
    View in: PubMed
    Score: 0.585
  2. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol. 2015 Aug; 35(8):1805-14.
    View in: PubMed
    Score: 0.326
  3. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013 Jan 01; 304(1):H131-41.
    View in: PubMed
    Score: 0.272
  4. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice. Am J Physiol Heart Circ Physiol. 2008 Dec; 295(6):H2436-46.
    View in: PubMed
    Score: 0.206
  5. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H343-51.
    View in: PubMed
    Score: 0.200
  6. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther. 2008 Aug; 22(4):275-82.
    View in: PubMed
    Score: 0.198
  7. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. Am J Physiol Heart Circ Physiol. 2007 Jun; 292(6):H2891-7.
    View in: PubMed
    Score: 0.183
  8. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation. 2006 Aug 29; 114(9):929-35.
    View in: PubMed
    Score: 0.177
  9. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1960-8.
    View in: PubMed
    Score: 0.169
  10. Grade 3 ischemia on the admission electrocardiogram predicts rapid progression of necrosis over time and less myocardial salvage by primary angioplasty. J Electrocardiol. 2005 Jul; 38(3):187-94.
    View in: PubMed
    Score: 0.164
  11. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther. 2003 Jan; 17(1):25-30.
    View in: PubMed
    Score: 0.138
  12. Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis. Cardiology. 2002; 97(3):166-74.
    View in: PubMed
    Score: 0.129
  13. Correlation between the electrocardiogram and regional wall motion abnormalities as detected by echocardiography in first inferior acute myocardial infarction. Cardiology. 2002; 98(1-2):81-91.
    View in: PubMed
    Score: 0.129
  14. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy. Cardiovasc Drugs Ther. 2020 12; 34(6):835-848.
    View in: PubMed
    Score: 0.117
  15. Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury? J Cardiovasc Pharmacol. 2020 02; 75(2):108-111.
    View in: PubMed
    Score: 0.113
  16. Circulating blood cells and extracellular vesicles in acute cardioprotection. Cardiovasc Res. 2019 06 01; 115(7):1156-1166.
    View in: PubMed
    Score: 0.108
  17. Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation. Cardiovasc Drugs Ther. 2018 12; 32(6):553-558.
    View in: PubMed
    Score: 0.104
  18. Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study. Cardiology. 2018; 140(3):178-185.
    View in: PubMed
    Score: 0.102
  19. Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy. Cell Physiol Biochem. 2018; 46(6):2284-2296.
    View in: PubMed
    Score: 0.100
  20. Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI. Scand Cardiovasc J. 2018 08; 52(4):189-195.
    View in: PubMed
    Score: 0.099
  21. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovasc Drugs Ther. 2016 Dec; 30(6):539-550.
    View in: PubMed
    Score: 0.091
  22. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension. 2013 May; 61(5):1008-13.
    View in: PubMed
    Score: 0.070
  23. Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus. Cardiovasc Drugs Ther. 2012 Dec; 26(6):445-56.
    View in: PubMed
    Score: 0.069
  24. Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012 Dec; 10(6):387-90.
    View in: PubMed
    Score: 0.068
  25. Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia. Am J Physiol Heart Circ Physiol. 2012 May 01; 302(9):H1806-17.
    View in: PubMed
    Score: 0.065
  26. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics. 2011 May 01; 43(10):534-42.
    View in: PubMed
    Score: 0.059
  27. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am J Physiol Heart Circ Physiol. 2010 May; 298(5):H1454-65.
    View in: PubMed
    Score: 0.057
  28. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. J Immunol. 2008 Sep 01; 181(5):3515-23.
    View in: PubMed
    Score: 0.051
  29. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007 Oct; 21(5):321-30.
    View in: PubMed
    Score: 0.048
  30. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1918-28.
    View in: PubMed
    Score: 0.047
  31. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. Prostaglandins Other Lipid Mediat. 2007 Aug; 84(1-2):43-53.
    View in: PubMed
    Score: 0.046
  32. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat. 2007 Feb; 83(1-2):89-98.
    View in: PubMed
    Score: 0.045
  33. Electrocardiographic diagnosis of ST-elevation myocardial infarction. Cardiol Clin. 2006 Aug; 24(3):343-65, vii.
    View in: PubMed
    Score: 0.044
  34. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther. 2006 Feb; 20(1):27-36.
    View in: PubMed
    Score: 0.043
  35. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res. 2005 Feb 01; 65(2):345-55.
    View in: PubMed
    Score: 0.040
  36. The grades of ischemia on the presenting electrocardiogram of patients with ST elevation acute myocardial infarction. J Electrocardiol. 2001; 34 Suppl:17-26.
    View in: PubMed
    Score: 0.030
  37. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997 Sep 02; 96(5):1641-6.
    View in: PubMed
    Score: 0.024
  38. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion. J Mol Cell Cardiol. 1997 Aug; 29(8):2013-25.
    View in: PubMed
    Score: 0.024
  39. Myocardial viability. West J Med. 1996 Dec; 165(6):364-71.
    View in: PubMed
    Score: 0.023
  40. The effect of coenzyme Q10 on infarct size in a rabbit model of ischemia/reperfusion. Cardiovasc Res. 1996 Nov; 32(5):861-8.
    View in: PubMed
    Score: 0.022
  41. Aleglitazar, a Balanced Dual PPARa and -? Agonist, Protects the Heart Against Ischemia-Reperfusion Injury. Cardiovasc Drugs Ther. 2016 Apr; 30(2):129-41.
    View in: PubMed
    Score: 0.022
  42. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc Res. 1998 Jul; 39(1):216-23.
    View in: PubMed
    Score: 0.006
  43. beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J. 1996 Aug; 132(2 Pt 1):258-62.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.